CRSP

CRISPR Therapeutics AG $52.96 1M -1.9% 3M +6.3% YTD -1.5% as of 2026-09-14
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings beat miss  ·  ring before open after close  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.7%
Next 1 week
+0.9%
Next 1 month
-1.3%
Seasonality
Weak window historically
Next 30 days (to Oct 15): -11.4% median, 33% of the last 9 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 60
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.27%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.78 -0.8% · Seasonal tilt (9y) -0.5%
$86M/day volume 59% volatility -5% 1-year -76% from ATH
52-week range · 26% of the way up · -32% from the high
$44.12$78.48

Congressional trades in CRSP Full tracker →

3 members · 3 buys / 4 sells · $182K–$430K disclosed · latest filing Oct 5, 2021.

SELL TS Thomas Suozzi · traded Sep 20, 2021 $50K–$100K
BUY TS Thomas Suozzi · traded Jun 3, 2021 $50K–$100K
BUY MG Marjorie Taylor Greene · traded Jan 21, 2021 $1K–$15K
SELL JI James M Inhofe · traded Jan 5, 2021 $1K–$15K
SELL JI James M Inhofe · traded Dec 22, 2020 $50K–$100K
SELL JI James M Inhofe · traded Jun 19, 2018 $15K–$50K
BUY JI James M Inhofe · traded Oct 19, 2017 $15K–$50K

Earnings Full history →

Next report 2026-11-09 (Monday, after close, in 55 days) · EPS est. -1.05.

1-day std dev
6.6%
Finished up
55%
Biggest pop
+25.2%
Biggest drop
-6.7%

Standard deviation of the close-to-close move over the last 40 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.